News
-
-
-
COMMUNIQUÉ DE PRESSE
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
CureVac announces financial results for the third quarter of 2024, including strengthened cash position, new oncology and prophylactic vaccine programs, workforce reduction, and new CFO appointment -
-
-
-
-
-
-